← Back to patent-cliff list
CAS 1609541-17-4
1-(2-(4-((1-(4-(benzyloxy)phenyl)hydrazinyl)methyl)phenoxy)ethyl)azepane
Codes: BAZE-028
Application context (from source-drug indications)
Oestrogen deficiency syndromeConjugated Estrogens/Bazedoxifene AcetateOsteoporosisConjugated Estrogens/Bazedoxifene AcetateVasomotor symptomsConjugated Estrogens/Bazedoxifene AcetateNon-invasive ductal carcinomaConjugated Estrogens/Bazedoxifene AcetateAnxietyConjugated Estrogens/Bazedoxifene AcetateMenopausal symptomsConjugated Estrogens/Bazedoxifene AcetatePostmenopausal osteoporosisBazedoxifene AcetateBreast cancerBazedoxifene AcetateOsteoporosisBazedoxifene AcetateMenopausal symptomsBazedoxifene Acetate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Conjugated Estrogens/Bazedoxifene Acetate | Tier C — Watch / trade | - |
| Bazedoxifene Acetate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole→1-(2-(4-((1-(4-(benzyloxy)phenyl)hydrazinyl)methyl)phenoxy)ethyl)azepane→1-(benzyloxy)-4-(prop-1-yn-1-yl)benzene
1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole→1-(2-(4-((1-(4-(benzyloxy)phenyl)hydrazinyl)methyl)phenoxy)ethyl)azepane→1-(benzyloxy)-4-(prop-1-yn-1-yl)benzene
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.